AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $3.780B
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| PAF | Ann: Net Tangible Asset Backing 20 April 2018 | 24/04/18 | 0 | 20 | |||
|
|||||||
| PAF | Ann: Quarterly Investment Manager Commentary - 31 March 2018 | 17/04/18 | 0 | 54 | |||
|
|||||||
| PAF | Ann: Net Tangible Asset Backing 13 April 2018 | 17/04/18 | 0 | 52 | |||
|
|||||||
| PAF | Ann: Net Tangible Asset Backing 6 April 2018 | 10/04/18 | 0 | 49 | |||
|
|||||||
| PAF | Ann: 31 March 2018 Investment Manager Monthly Commentary | 10/04/18 | 0 | 46 | |||
|
|||||||
| PAF | Ann: Appendix 3B - DRP | 05/04/18 | 0 | 30 | |||
|
|||||||
| PAF | Ann: Net Tangible Asset Backing 31 March 2018 | 04/04/18 | 0 | 44 | |||
|
|||||||
| PAF | Ann: Update - Dividend/Distribution - PAF | 03/04/18 | 0 | 51 | |||
|
|||||||
See All Discussions
ASX News